Lisa Lindesmith

17PUBLICATIONS
108CO-AUTHORS
Fish pests and diseasesMedical molecular engineering of nucleic acids and proteinsMolecular targetsInnate immunityHost-parasite interactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 08, 2026
Epidemiology and molecular evolution of norovirus GII.17 in the United States, 2021-2025.

|Mar 27, 2026
One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine development.

Nathan A Ona, Dapeng Zhang, Lisa C Lindesmith

|May 14, 2025
An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study.

Becca A Flitter, Joshua Gillard, Susan N Greco

|Mar 05, 2025
Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus.

Juyeon Park, Lisa C Lindesmith, Adam S Olia

|Mar 04, 2025
Molecular Evolution and Epidemiology of Norovirus GII.4 Viruses in the United States.

Leslie Barclay, Anna M Montmayeur, Jennifer L Cannon

|Oct 01, 2024
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection.

Elena N Atochina-Vasserman, Lisa C Lindesmith, Carmen Mirabelli

Pageof 3

Frequent Collaborators

15 joint publications

Ralph S Baric

6 joint publications

Michael Mallory

3 joint publications

Elena N Atochina-Vasserman

3 joint publications

Jan Vinjé